Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Multiple Endocrine Neoplasia Type 1 5Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Motor Activity 1Metabolic Diseases 1Melanoma 1Inflammation 1Feeding Behavior 1Esophageal Neoplasms 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Colorectal Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

Etanercept 3Methotrexate 2Adalimumab 2secukinumab 1purine 1fumaric acid 1deucravacitinib 1apremilast 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Nivolumab 1Methods 1Mesalamine 1Mercaptopurine 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Folic Acid 1Fish Oils 1Fatty Acids, Omega-3 1Exercise 1Eicosapentaenoic Acid 1Educational Status 1Eating 1Early Intervention, Educational 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Psoriasis × Eating × Clear all
NCT03253666 2020-07-15

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)

Completed
173,229 enrolled
Dermatologic

Dermatitis, Atopic, Melanoma, Psoriasis, Rosacea, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡